SCP
PRTA icon

Syntal Capital Partners’s Prothena Corp PRTA Stock Holding History

Syntal Capital Partners’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33,615
Closed -$2.39M – 99
2021
Q3 		$2.39M Buy
+33,615
New +$2.09M 0.83% 24

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Syntal Capital Partners's PRTA Position: Q4 2021 in Review

Syntal Capital Partners sold out of Prothena Corp (PRTA) in Q4 2021, closing a stake of 33,615 shares — an estimated $2.39M sold.

Syntal Capital Partners first reported a position in PRTA in Q3 2021 and held it in 1 quarter. The position peaked at $2.39M in Q3 2021. 196 funds tracked by Wall St. Rank hold PRTA as of Q4 2021.

  • Syntal Capital Partners reported no remaining Prothena Corp position as of Q4 2021 after selling out during the quarter.
  • Syntal Capital Partners sold 33,615 Prothena Corp shares in Q4 2021, an estimated $2.39M.
  • Syntal Capital Partners first reported a position in Prothena Corp in Q3 2021 and held it in 1 quarter.
  • Syntal Capital Partners's Prothena Corp position peaked at $2.39M in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2021.

Based on Syntal Capital Partners's 13F filing for Q4 2021, filed 11 Feb 2022.